Effects of smoking on ocular health

Current Opinion in Ophthalmology

Volumn 22, Issue 6, 2011, Pages 477-482

  Galor, Anat ^a,b   Lee, David J ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

age related macular degeneration; ocular health; ocular inflammation; smoking; thyroidassociated orbitopathy

Indexed keywords

COMPLEMENT FACTOR H;

AUSTRALIA; BEHCET DISEASE; CANADA; CATARACT; CIGARETTE SMOKING; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA POLYMORPHISM; EYE; EYE INFLAMMATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; HEALTH HAZARD; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PROTEIN INTERACTION; RACE; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; UNITED KINGDOM; UNITED STATES; VISION;

EYE DISEASES; HUMANS; MACULAR DEGENERATION; SMOKING;

EID: 80054922072     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32834bbe7a     Document Type: Review

References (52)

1. US Department of Health and Human Services. Chapter 2: the changing cigarette. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease - a report of the surgeon general. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2010. pp. 13-26
2. Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol 2001; 14:767-790. (Pubitemid 32663874)
3. Kroon LA. Drug interactions with smoking. Am J Health Syst Pharm 2007; 64:1917-1921. (Pubitemid 47462906)
4. Zeidler R, Albermann K, Lang S. Nicotine and apoptosis. Apoptosis 2007; 12:1927-1943. (Pubitemid 47498221)
5. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 2006; 15:737-745.
6. Other Effects. Surgeon General's Report: The Health Consequences of Smoking; 2004. pp. 777-801.
7. Thorne JE, Daniel E, Jabs DA, et al. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol 2008; 145:841-846.
8. Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology 2010; 117:585-590.
9. Roesel M, Ruttig A, Schumacher C, et al. Smoking complicates the course of noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol 2011; 249:903-907.
10. Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol 2002; 86:1347-1351. (Pubitemid 35408632)
11. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 2000; 118:1264-1268.
12. Boonman ZF, de Keizer RJ, Watson PG. Smoking delays the response to treatment in episcleritis and scleritis. Eye 2005; 19:949-955. (Pubitemid 43114974)
13. Galor A, Feuer W, Kempen JH, et al. Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol 2010; 94:848-853.
14. Kaklamani VG, Markomichelakis N, Kaklamanis PG. Could nicotine be beneficial for Behçet's disease? Clin Rheumatol 2002; 21:341-342.
15. Rizvi SW, McGrath H Jr. The therapeutic effect of cigarette smoking on oral/ genital aphthosis and other manifestations of Behçet's disease. Clin Exp Rheumatol 2001; 19 (5 Suppl 24):S77-S78.
16. Ciancio G, Colina M, La Corte R, et al. Nicotine-patch therapy on mucocutaneous lesions of Behçet's disease: a case series. Rheumatology (Oxford) 2010; 49:501-504.
17. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308:419-421. (Pubitemid 40530081)
18. Edwards AO, Ritter R 3rd, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308:421-424. (Pubitemid 40530082)
19. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in agerelated macular degeneration. Science 2005; 308:385-389. (Pubitemid 40530070)
20. Chu J, Zhou CC, Lu N, et al. Genetic variants in three genes and smoking show strong associations with susceptibility to exudative age-related macular degeneration in a Chinese population. Chin Med J (Engl) 2008; 121:2525-2533.
21. Hageman GS, Anderson DH, Johnson LV, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 2005; 102:7227-7232. (Pubitemid 40696361)
22. Seddon JM, Reynolds R, Maller J, et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 2009; 50:2044-2053.
23. Katta S, Kaur I, Chakrabarti S. The molecular genetic basis of age-related macular degeneration: an overview. J Genet 2009; 88:425-449.
24. Schaumberg DA, Hankinson SE, Guo Q, et al. A prospective study of 2 major age-related macular degeneration susceptibility alleles and interactions with modifiable risk factors. Arch Ophthalmol 2007; 125:55-62. (Pubitemid 46072376)
25. Lee SJ, Kim NR, Chin HS. LOC387715/HTRA1 polymorphisms, smoking and combined effects on exudative age-related macular degeneration in a Korean population. Clin Experiment Ophthalmol 2010; 38:698-704.
26. Wang JJ, Ross RJ, Tuo J, et al. The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Ophthalmology 2008; 115:693-699. (Pubitemid 351443012)
27. Francis PJ, George S, Schultz DW, et al. The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered 2007; 63 (3-4):212-218. (Pubitemid 46457590)
28. Schaumberg DA, Chasman D, Morrison MA, et al. Prospective study of common variants in the retinoic acid receptor-related orphan receptor alpha gene and risk of neovascular age-related macular degeneration. Arch Ophthalmol 2010; 128:1462-1471.
29. Ayala-Haedo JA, Gallins PJ, Whitehead PL, et al. Analysis of single nucleotide polymorphisms in the NOS2A gene and interaction with smoking in age-related macular degeneration. Ann Hum Genet 2010; 74:195-201.
30. Nakanishi H, Yamashiro K, Yamada R, et al. Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2010; 51:6183-6187.
31. Berendschot TT, Willemse-Assink JJ, Bastiaanse M, et al. Macular pigment and melanin in age-related maculopathy in a general population. Invest Ophthalmol Vis Sci 2002; 43:1928-1932. (Pubitemid 34587043)
32. Pons M, Marin-Castano ME. Nicotine increases VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Invest Ophthalmol Vis Sci 2011.
33. Kang JH, Wiggs JL, Rosner BA, et al. Endothelial nitric oxide synthase gene variants and primary open-angle glaucoma: interactions with hypertension, alcohol intake, and cigarette smoking. Arch Ophthalmol 2011; 129:773-780.
34. Sahai A,Malik P. Dry eye: prevalence and attributable risk factors in a hospitalbased population. Indian J Ophthalmol 2005; 53:87-91.
35. Ward SK, Dogru M, Wakamatsu T, et al. Passive cigarette smoke exposure and soft contact lens wear. Optom Vis Sci 2010; 87:367-372.
36. West S, Munoz B, Schein OD, et al. Cigarette smoking and risk for progression of nuclear opacities. Arch Ophthalmol 1995; 113:1377-1380.
37. Klein BE, Klein R, Linton KL, Franke T. Cigarette smoking and lens opacities: the Beaver Dam Eye Study. Am J Prev Med 1993; 9:27-30. (Pubitemid 23089460)
38. Christen WG, Manson JE, Seddon JM, et al. A prospective study of cigarette smoking and risk of cataract in men. JAMA 1992; 268:989-993.
39. Krishnaiah S, Vilas K, Shamanna BR, et al. Smoking and its association with cataract: results of the Andhra Pradesh eye disease study from India. Invest Ophthalmol Vis Sci 2005; 46:58-65. (Pubitemid 40041179)
40. Wu R, Wang JJ, Mitchell P, et al. Smoking, socioeconomic factors, and agerelated cataract: the Singapore Malay Eye study. Arch Ophthalmol 2010; 128:1029-1035.
41. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Surv Ophthalmol 1998; 42:535-547. (Pubitemid 28272741)
42. Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption. Clin Endocrinol (Oxf) 1996; 45:477-481. (Pubitemid 26383428)
43. Shine B, Fells P, Edwards OM, Weetman AP. Association between Graves? ophthalmopathy and smoking. Lancet 1990; 335:1261-1263.
44. Prummel MF, Wiersinga WM. Smoking and risk of Graves? disease. JAMA 1993; 269:479-482.
45. Lee JH, Lee SY, Yoon JS. Risk factors associated with the severity of thyroidassociated orbitopathy in Korean patients. Korean J Ophthalmol 2010; 24:267-273.
46. Lim SL, Lim AK, Mumtaz M, et al. Prevalence, risk factors, and clinical features of thyroid-associated ophthalmopathy in multiethnic Malaysian patients with Graves? disease. Thyroid 2008; 18:1297-1301.
47. Eckstein A, Quadbeck B, Mueller G, et al. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy. Br J Ophthalmol 2003; 87:773-776. (Pubitemid 36649234)
48. Tsai CC, Cheng CY, Liu CY, et al. Oxidative stress in patients with Graves? ophthalmopathy: relationship between oxidative DNA damage and clinical evolution. Eye (Lond) 2009; 23:1725-1730.
49. Hegedius L, Brix TH, Vestergaard P. Relationship between cigarette smoking and Graves? ophthalmopathy. J Endocrinol Invest 2004; 27:265-271. (Pubitemid 38607480)
50. Cawood TJ, Moriarty P, O?Farrelly C, O?Shea D. Smoking and thyroidassociated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab 2007; 92:59-64. (Pubitemid 46067509)
51. Kennedy RD, Spafford MM, Parkinson CM, Fong GT. Knowledge about the relationship between smoking and blindness in Canada, the United States, the United Kingdom, and Australia: results from the International Tobacco Control Four-Country Project. Optometry 2011; 82:310-317.
52. Kanonidou E, Konidaris V, Kanonidou C, Praidou A. An evaluation of the young people's knowledge regarding the ophthalmic effects of smoking. Bull Soc Belge Ophtalmol 2010; 315:31-38.